Donald McDonnell, Professor in the Department of Pharmacology and Cancer Biology at Duke University School of Medicine, shared Robert Abraham’s, Chief Scientific Officer at Engine Biosciences, post on LinkedIn, adding:
“Looking forward to participating in this meeting for the first time!
Looking over the 2026 program and past programs it is clear that I missed a great opportunity by not putting this on my calendar every year.”
Quoting Robert Abraham’s post:
“For those of my friends and colleagues who have attended a CMTRA meeting previously, you are already aware that it provides an exceptional opportunity to update your knowledge about cancer biology and therapy. For those who have not attended a prior CMTRA meeting, I urge to join us in Utah for the 2026 meeting – you will be hooked like I am!”
Other articles featuring Donald McDonnell on OncoDaily.